GSK shares plunge 8% on profit warning

A shock profit warning from GlaxoSmithKline sent its shares plummeting yesterday after the drug giant said "the shadow of Avandia would continue to make life difficult" in 2008.

Sales of the blockbuster diabetes drug Avandia fell by almost a third in the US last year following the publication of a report that linked it to an increased risk of heart attack. In the fourth quarter, sales were down 55 per cent to £130m.

GSK yesterday warned that earnings would fall this year due to weaker Avandia sales and fierce competition from generic drugs.

Shares in the company plunged 7.6 per cent, down 89p to 1,078p, the lowest level since 2004. The price had fallen as much as 9.5 per cent earlier in the day, the biggest daily decline for the group since it was formed in 2000.

Presenting his last set of results before he retires in May, GSK's chief executive, Jean-Pierre Garnier, said earnings per share would fall "by a mid-single-digit percentage" at constant exchange rates.

"The shadow of Avandia will continue over us in 2008 and make life a little bit more difficult for us," he warned. "But underneath all this, you have a very strong business. In fact, without the Avandia incident, the company would have grown 19 percent in 2007."

Analysts said the outlook was disappointing. Ben Yeoh, at Dresdner Kleinwort, said: "Consensus expectations were for low- to mid-single-digit earnings growth in 2008, and they are talking about a decline."

GSK has vigorously disputed the findings of the academic article on Avandia, which appeared in The New England Journal of Medicine last May. The drug company said the benefits of Avandia far outweighed any risks, but any turnaround in the product's fortunes are expected to take some time.

To add to the problems, delays in the portfolio of new drugs at GSK has dented investor confidence. The cervical cancer vaccine Cervarix, considered by some analysts to be the most important new product for Glaxo this decade, suffered a setback after the US Food and Drug Administration delayed approval of the treatment in December, pending more information.

Mr Garnier said the company expected to update the agency on Cervarix by the third quarter of 2008, which means the drug is unlikely to go on sale in the US before 2009.

Sales of the company's best seller, the asthma drug Advair, rose to £3.5bn from £3.3bn in 2006, but analysts are concerned that growth is slowing.

The company also flagged up heavier generic-drug competition to products such as Wellbutrin and Coreg, which treat depression and hypertension, respectively.

The impact of generic rivals added to a 3 per cent fall in US pharmaceutical sales to £9.3bn, while sterling's strength against the dollar left the group's overall revenues down 2 per cent to £22.7bn. Pre-tax profits came in ahead of forecasts at £7.8bn.

The group has embarked on a cost-cutting programme aimed at saving £700m a year by 2010. GSK said the savings would partly offset the impact of generic competition and the Avandia sales drop this year.

Despite the concerns, Mr Garnier said the company remained confident about the future. "Our fast-growing vaccines business, the resurgence of our consumer healthcare division and the strong performance of many key pharmaceutical products are all providing contributions to growth," he said.

GSK's incoming chief executive, Andrew Witty, said he had no intention of selling the consumer healthcare division, which owns brands such as the painkiller Panadol, Aquafresh toothpaste and drinks such as Lucozade, Horlicks and Ribena. The division saw sales increase by 14 per cent to nearly £3.5bn last year.

Start your day with The Independent, sign up for daily news emails
Sport
Seth Rollins cashes in his Money in the Bank contract to win the WWE World Heavyweight Championship
WWERollins win the WWE World Heavyweight title in one of the greatest WrestleMania's ever seen
Arts and Entertainment
Louis Theroux: By Reason of Insanity takes him behind the bars again
tvBy Reason of Insanity, TV review
Arts and Entertainment
Cassetteboy's latest video is called Emperor's New Clothes rap
videoThe political parody genius duo strike again with new video
Arts and Entertainment
tvPoldark, TV review
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Retirement Coordinator - Financial Services

Negotiable: Recruitment Genius: To provide a prompt, friendly and efficient se...

Recruitment Genius: Annuities / Pensions Administrator

Negotiable: Recruitment Genius: You will be the first point of contact for all...

Ashdown Group: HR, Payroll & Benefits Officer - Altrincham - up to £24,000.

£18000 - £24000 per annum + benefits: Ashdown Group: HR, Payroll & Benefits Of...

Ashdown Group: Learning and Development Programme Manager

£35000 - £38000 per annum + benefits : Ashdown Group: A highly successful, int...

Day In a Page

No postcode? No vote

Floating voters

How living on a houseboat meant I didn't officially 'exist'
Louis Theroux's affable Englishman routine begins to wear thin

By Reason of Insanity

Louis Theroux's affable Englishman routine begins to wear thin
Power dressing is back – but no shoulderpads!

Power dressing is back

But banish all thoughts of Eighties shoulderpads
Spanish stone-age cave paintings 'under threat' after being re-opened to the public

Spanish stone-age cave paintings in Altamira 'under threat'

Caves were re-opened to the public
'I was the bookies’ favourite to be first to leave the Cabinet'

Vince Cable interview

'I was the bookies’ favourite to be first to leave the Cabinet'
Election 2015: How many of the Government's coalition agreement promises have been kept?

Promises, promises

But how many coalition agreement pledges have been kept?
The Gaza fisherman who built his own reef - and was shot dead there by an Israeli gunboat

The death of a Gaza fisherman

He built his own reef, and was fatally shot there by an Israeli gunboat
Saudi Arabia's airstrikes in Yemen are fuelling the Gulf's fire

Saudi airstrikes are fuelling the Gulf's fire

Arab intervention in Yemen risks entrenching Sunni-Shia divide and handing a victory to Isis, says Patrick Cockburn
Zayn Malik's departure from One Direction shows the perils of fame in the age of social media

The only direction Zayn could go

We wince at the anguish of One Direction's fans, but Malik's departure shows the perils of fame in the age of social media
Young Magician of the Year 2015: Meet the schoolgirl from Newcastle who has her heart set on being the competition's first female winner

Spells like teen spirit

A 16-year-old from Newcastle has set her heart on being the first female to win Young Magician of the Year. Jonathan Owen meets her
Jonathan Anderson: If fashion is a cycle, this young man knows just how to ride it

If fashion is a cycle, this young man knows just how to ride it

British designer Jonathan Anderson is putting his stamp on venerable house Loewe
Number plates scheme could provide a licence to offend in the land of the free

Licence to offend in the land of the free

Cash-strapped states have hit on a way of making money out of drivers that may be in collision with the First Amendment, says Rupert Cornwell
From farm to fork: Meet the Cornish fishermen, vegetable-growers and butchers causing a stir in London's top restaurants

From farm to fork in Cornwall

One man is bringing together Cornwall's most accomplished growers, fishermen and butchers with London's best chefs to put the finest, freshest produce on the plates of some of the country’s best restaurants
Robert Parker interview: The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes

Robert Parker interview

The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes
Don't believe the stereotype - or should you?

Don't believe the stereotype - or should you?

We exaggerate regional traits and turn them into jokes - and those on the receiving end are in on it too, says DJ Taylor